Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1959 1
1962 9
1963 11
1964 7
1965 15
1966 21
1967 11
1968 11
1969 15
1970 12
1971 16
1972 13
1973 19
1974 26
1975 9
1976 25
1977 25
1978 21
1979 35
1980 24
1981 15
1982 23
1983 37
1984 21
1985 47
1986 35
1987 45
1988 45
1989 47
1990 37
1991 42
1992 44
1993 50
1994 60
1995 53
1996 63
1997 65
1998 65
1999 83
2000 63
2001 70
2002 59
2003 51
2004 83
2005 74
2006 74
2007 86
2008 93
2009 93
2010 98
2011 80
2012 107
2013 107
2014 108
2015 116
2016 105
2017 90
2018 99
2019 111
2020 120
2021 110
2022 138
2023 134
2024 111
2025 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,351 results

Results by year

Filters applied: . Clear all
Page 1
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer.
Mikami H, Feng S, Matsuda Y, Ishii S, Naoi S, Azuma Y, Nagano H, Asanuma K, Kayukawa Y, Tsunenari T, Kamikawaji S, Iwabuchi R, Shinozuka J, Yamazaki M, Kuroi H, Ho SSW, Gan SW, Chichili P, Pang CL, Yeo CY, Shimizu S, Hironiwa N, Kinoshita Y, Shimizu Y, Sakamoto A, Muraoka M, Takahashi N, Kawa T, Shiraiwa H, Mimoto F, Kashima K, Kamata-Sakurai M, Ishikawa S, Aburatani H, Kitazawa T, Igawa T. Mikami H, et al. Among authors: ishikawa s. Cancer Immunol Res. 2024 Jun 4;12(6):719-730. doi: 10.1158/2326-6066.CIR-23-0638. Cancer Immunol Res. 2024. PMID: 38558120
Multiancestry genomic and transcriptomic analysis of gastric cancer.
Totoki Y, Saito-Adachi M, Shiraishi Y, Komura D, Nakamura H, Suzuki A, Tatsuno K, Rokutan H, Hama N, Yamamoto S, Ono H, Arai Y, Hosoda F, Katoh H, Chiba K, Iida N, Nagae G, Ueda H, Shihang C, Sekine S, Abe H, Nomura S, Matsuura T, Sakai E, Ohshima T, Rino Y, Yeoh KG, So J, Sanghvi K, Soong R, Fukagawa A, Yachida S, Kato M, Seto Y, Ushiku T, Nakajima A, Katai H, Tan P, Ishikawa S, Aburatani H, Shibata T. Totoki Y, et al. Among authors: ishikawa s. Nat Genet. 2023 Apr;55(4):581-594. doi: 10.1038/s41588-023-01333-x. Epub 2023 Mar 13. Nat Genet. 2023. PMID: 36914835
Reply.
Sugisaki K, Inoue T, Yoshikawa K, Kanamori A, Yamazaki Y, Ishikawa S, Uchida K, Iwase A, Araie M. Sugisaki K, et al. Among authors: ishikawa s. Ophthalmology. 2022 Aug;129(8):e82-e83. doi: 10.1016/j.ophtha.2022.03.025. Epub 2022 May 20. Ophthalmology. 2022. PMID: 35599066 No abstract available.
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor.
Tanada M, Tamiya M, Matsuo A, Chiyoda A, Takano K, Ito T, Irie M, Kotake T, Takeyama R, Kawada H, Hayashi R, Ishikawa S, Nomura K, Furuichi N, Morita Y, Kage M, Hashimoto S, Nii K, Sase H, Ohara K, Ohta A, Kuramoto S, Nishimura Y, Iikura H, Shiraishi T. Tanada M, et al. Among authors: ishikawa s. J Am Chem Soc. 2023 Aug 2;145(30):16610-16620. doi: 10.1021/jacs.3c03886. Epub 2023 Jul 18. J Am Chem Soc. 2023. PMID: 37463267
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.
Li M, Nishimura T, Takeuchi Y, Hongu T, Wang Y, Shiokawa D, Wang K, Hirose H, Sasahara A, Yano M, Ishikawa S, Inokuchi M, Ota T, Tanabe M, Tada KI, Akiyama T, Cheng X, Liu CC, Yamashita T, Sugano S, Uchida Y, Chiba T, Asahara H, Nakagawa M, Sato S, Miyagi Y, Shimamura T, Nagai LAE, Kanai A, Katoh M, Nomura S, Nakato R, Suzuki Y, Tojo A, Voon DC, Ogawa S, Okamoto K, Foukakis T, Gotoh N. Li M, et al. Among authors: ishikawa s. J Clin Invest. 2023 Nov 15;133(22):e166666. doi: 10.1172/JCI166666. J Clin Invest. 2023. PMID: 37966117 Free PMC article.
Discovery of ^{39}Na.
Ahn DS, Amano J, Baba H, Fukuda N, Geissel H, Inabe N, Ishikawa S, Iwasa N, Komatsubara T, Kubo T, Kusaka K, Morrissey DJ, Nakamura T, Ohtake M, Otsu H, Sakakibara T, Sato H, Sherrill BM, Shimizu Y, Sumikama T, Suzuki H, Takeda H, Tarasov OB, Ueno H, Yanagisawa Y, Yoshida K. Ahn DS, et al. Among authors: ishikawa s. Phys Rev Lett. 2022 Nov 18;129(21):212502. doi: 10.1103/PhysRevLett.129.212502. Phys Rev Lett. 2022. PMID: 36461972
Pathology Foundation Models.
Ochi M, Komura D, Ishikawa S. Ochi M, et al. Among authors: ishikawa s. JMA J. 2025 Jan 15;8(1):121-130. doi: 10.31662/jmaj.2024-0206. Epub 2024 Dec 20. JMA J. 2025. PMID: 39926091 Free PMC article. Review.
Flexible bronchofiberscope.
Ikeda S, Tsuboi E, Ono R, Ishikawa S. Ikeda S, et al. Among authors: ishikawa s. Jpn J Clin Oncol. 2010 Sep;40(9):e55-64. doi: 10.1093/jjco/hyq114. Jpn J Clin Oncol. 2010. PMID: 20736215 No abstract available.
Clonal Hematopoiesis and Solid Cancers.
Nguyen YTM, Fujisawa M, Ishikawa S, Sakata-Yanagimoto M. Nguyen YTM, et al. Among authors: ishikawa s. Cancer Sci. 2025 May 19. doi: 10.1111/cas.70097. Online ahead of print. Cancer Sci. 2025. PMID: 40384356 Free article. Review.
3,351 results